A Skeptic’s Guide to Ozempic and Other GLP-1 Agonists - Skeptic
Google News • 1/19/2026 – 1/21/2026
Summary
A Skeptic’s Guide to Ozempic and Other GLP-1 Agonists discusses the impact of weight-loss injections, including their effects on individuals and the pharmaceutical industry. The Financial Times reviews "Off the Scales," which examines Ozempic's global reach and its implications for perceptions of obesity. Additionally, a dietitian shares information about supplements that function similarly to Ozempic, as reported by the Daily Mail. The Grand Valley Lanthorn highlights the interests of Big Pharma in promoting weight loss.
Advertisement
Lindy Score Breakdown (V4.2)
37d
Age
1
Sources
from cluster
856
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^856/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^856/48 = 0.000004) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 37 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
Stat News • 1 day ago
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News • 1 day ago
STAT+: Digital twins, the holy grail of preventative health, are still only a ‘Frankensteinian proof of principle’
Stat News • 2 days ago
STAT+: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer treatments
Stat News • 2 days ago
STAT+: People with intellectual and development disabilities have higher rates of anxiety, depression
Stat News • 2 days ago
STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News • 2 days ago
STAT+: Novo doubles down on oral peptides
Stat News • Today
Opinion: The Rural Health Transformation Program could fail patients like mine
Stat News • 1 day ago
STAT+: FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications
Stat News • 2 days ago